This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




Text Version    RSS    Subscribe    Unsubscribe    Archive    Media Kit           September 02, 2015

Home     About SGO    Education    Membership    Clinical Practice    Public Policy    Blog    Partnerships    Store

 

Obama calls for a greater effort to fight ovarian cancer
The Huffington Post
President Barack Obama honored women diagnosed with ovarian cancer and their families and urged more research into prevention, detection and treatment of the disease in a White House proclamation commemorating September as National Ovarian Cancer Awareness Month.

“This month, we stand with all those who continue to fight this devastating disease and with those who have lost loved ones because of it. Along with the advocates, medical researchers, and health care providers who tirelessly battle this disease every day, we rededicate ourselves to the urgent work of increasing awareness and improving care for those with ovarian cancer — and we continue forging a future free from cancer in all its forms,” the proclamation reads.
Click here to read more.

(Tweet your support for ovarian cancer research! #ovariancancer #gyncsm @SGO2015)
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article




SGO NEWS


September is Gynecologic Cancer Awareness Month
During the month of September, SGO salutes all members of a woman’s gynecologic cancer team. Thank you for your efforts in research and clinical trials, diligence in educating others within our subspecialty, advocacy work with our elected officials, and commitment to your patients on a daily basis.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


OVARIAN CANCER


Younger age predicts worse survival from low-grade serous carcinoma of ovary, peritoneum
Healio
Women aged 35 or younger with low-grade serous carcinoma of the ovary or the peritoneum, as well as those with persistent disease upon therapy completion, have worse survival outcomes than older women with the same cancers, according to observational study results published in the Journal of Clinical Oncology. Further, patients with low-grade serous carcinoma of the peritoneum (LGSPC) appear to have a better prognosis than patients with low-grade serous carcinoma of the ovary (LGSOC).
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Advertisement
SPONSORED CONTENT


Beta-blockers linked with extended ovarian cancer survival
Cancer Network
Beta-blockers were associated with increased overall survival in women with epithelial ovarian cancer, according to the results of a recently published retrospective study in the journal Cancer. In the analysis, women who received any beta-blocker had a more than 5-month increase in median overall survival compared with women not receiving beta-blockers.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


BREAST CANCER


New blood test could predict breast cancer relapse risk
CBS News
Weeks or even months before there is evidence of a tumor in scans or biopsies, a simple blood test could detect the risk of relapse in survivors of early stage breast cancer. The "liquid biopsy" developed at the Institute of Cancer Research in London is a kind of blood test that shows promise in detecting cancer DNA in the blood before the cells grow into tumors. The results of a prospective pilot study of the test were published in the journal Science Translational Medicine.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Advertisement
PRODUCT SHOWCASE
  ChemoFx Improves Ovarian Cancer Outcomes
ChemoFx® provides invaluable information to physicians choosing from 20+ equivalent treatment recommendations without prior knowledge of how individual patients may respond. ChemoFx determines platinum resistance in primary ovarian cancer and demonstrates longer overall survival by 14 months in recurrent ovarian cancer, making it instrumental in improving patient outcomes.
 


CHEMOTHERAPY


Risk protocol identifies patients with cancer not allergic to carboplatin, oxaliplatin
Healio
Patients with cancer who had a history of presumed carboplatin- and oxaliplatin-induced hypersensitivity reaction did not appear allergic to the chemotherapy drugs after skin prick tests, according to retrospective study results published in Annals of Allergy, Asthma & Immunology. The risk-stratification protocol appeared to safely identify patients without allergic reaction to the drugs, allowing them to return to an outpatient setting for further treatment without desensitization.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Genetic test impacts chemo choices in surprising ways
TIME
A study investigates for the first time how a gene-based test is affecting women’s decisions to get chemotherapy. In the new era of personalized medicine, having more information on hand is considered the ideal situation for making more customized, and ideally, effective decisions about medical care. And in a new study, published in JAMA Oncology, of breast cancer patients, researchers show that a relatively new genetic test for evaluating tumors is doing just that. It’s just that the test isn’t necessarily leading to the decisions that experts expected.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Advertisement
  Ovarian cancer updates from ASCO 2015:

Four prominent experts in ovarian cancer met in Chicago to provide perspectives related to progress made toward personalized therapy. More
 


OUTCOMES


Ureteric injury risk with hysterectomy increased
HealthDay News via Renal & Urology News
In 2001 to 2010, 0.5 percent of women experienced ureteric injury in the year after a hysterectomy, with lower rates for benign versus malignant conditions and rates of injury increasing between 2001 and 2010, according to a study published online in BJOG: An International Journal of Obstetrics and Gynaecology. Amit Kiran, Ph.D., from the London School of Hygiene & Tropical Medicine, and colleagues examined the rates of ureteric injury among women undergoing hysterectomy in a retrospective cohort study. The main outcome measure was ureteric injury within 1 year of hysterectomy.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




Effectiveness of cancer survivorship care plans questioned
Medscape (free login required)
Survivorship care plans (SCPs), recommended for cancer survivors by the Institute of Medicine since 2006, are meant to improve patients' quality of care as they move beyond cancer treatment and deal with its aftermath. But do they work? In a study published online Aug. 24 in the Journal of Clinical Oncology, Dutch researchers found "no evidence of a benefit of SCPs on satisfaction with information provision and care."
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


MISSED AN ISSUE OF WOMEN'S CANCER NEWS?
Visit the SGO Women's Cancer News archive page.


 



Women's Cancer News
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Jessica Taylor, Senior Medical Editor, 202-684-7169  
Contribute news


Inclusion of advertisements does not constitute SGO endorsement of company products or services.

Be sure to add us to your address book or safe sender list so our emails get to your inbox. Learn how.

This edition of the Women's Cancer News was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!

Recent issues

Aug. 26, 2015
Aug. 19, 2015
Aug. 12, 2015
Aug. 5, 2015






7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063